Free Trial

Axsome Therapeutics (AXSM) SEC Filings & 10K Form

Axsome Therapeutics logo
$107.89 -1.86 (-1.69%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$107.34 -0.56 (-0.51%)
As of 04/3/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Axsome Therapeutics SEC Filings

DateFilerForm TypeView
04/01/2025
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2025
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
6:56 PM
Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:57 PM
Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:59 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:00 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:02 PM
Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:51 PM
Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:53 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:54 PM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
8:20 PM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
8:00 AM
Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/10/2025
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2024
6:56 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
8:43 AM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
5:23 PM
Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
4:24 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
6:00 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:32 PM
Axsome Therapeutics (Subject)
Saad Mark E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:27 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
3:30 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
3:30 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:31 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:31 PM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:32 PM
Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:38 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
7:11 PM
Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
7:12 PM
Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:28 PM
Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
4:20 PM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:AXSM) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners